What influence do circulating myeloma plasma cells have on the treatment of multiple myeloma?
The differences between biological and chronological age, with their implications on AML treatment
Which treatments are currently available for relapsed and refractory myeloma treatment?
ASH 2015 highlights in multiple myeloma by Prof. Ola Landgren
The impact of new drugs and the changing role of transplants in multiple myeloma